Table 3.
Review of dynamic transmission economic evaluations in low‐ and middle‐income countries (mosquito‐borne diseases, any publication year)
| First author | Year | Country or region | CHEERS review | ||||
|---|---|---|---|---|---|---|---|
| Perspective (6.) | Intervention (7.) | Time horizon (8.) | Health outcome measure (10.) | Describes costs including sources and approximations using opportunity cost (13b.) | |||
| Okell | 2014 | Africa | Provider | Treatment | 5 years | Infections averted | Clear description of costs and sources |
| Stuckey | 2014 | Kenya | Societal | Multiple | 5 years | DALY and infections averted and mortality | Clear description of costs and sources |
| Briët (a) | 2013 | Not specified | Provider (‘health system’) | Vector control | Lifetime of the intervention | DALY and NHB | Refers to previous paper |
| Briët (b) | 2013 | Not specified | Provider (health system) | Vector control | Lifetime of the intervention | DALY and infections averted and NHB | Some information but not comprehensive |
| Briët (c) | 2013 | Not specified | Provider (health system) | Vector control | 60 years | DALY and NHB | Some information but not comprehensive |
| Crowell | 2013 | Sub‐Saharan Africa | Provider | MSAT | 1 year | Infections averted | Clear description of costs and sources |
| Okosun (a) | 2013 | Not specified | Not found | Multiple | 140 days | Infections averted | Little information |
| Durhama | 2013 | Brazil | Societal (but only cost of vaccine and cost of illness) | Vaccine | 73 years | DALY and NHB | Some information. Cites a study on the cost of dengue treatment in the Americas, little information on processing or generalisability |
| Okosun (b) | 2012 | Not specified | Not found | Multiple | 1 year | Infections averted | Little information |
| Maire | 2011 | Sub‐Saharan Africa | Societal | Vaccine | 10 years | DALY | Clear description of costs and sources |
| Ross | 2011 | Sub‐Saharan Africa | Provider (implied) | Intermittent presumptive treatment | 10 years | DALY | Some information. Describes intervention costs but does not report case management unit costs in the methods |
| Okosun (c) | 2011 | Not specified | Not found | Multiple | 100 days | Infections averted | Little information |
| Luza | 2011 | Brazil | Societal | Vector control | 5 years | DALY | Clear description of costs and sources (in web appendix) |
| Tediosi (a) | 2009 | Tanzania | Societal | Vaccine | 10 years | DALY and infections averted | Clear description of costs and sources, although referencing is relied on |
| Tediosi (b) | 2006 | Tanzania | Societal | Vaccine | 20 years | DALY and life years and infections averted and mortality | Clear description of costs and sources, although referencing is relied on (reference paper is part of the same journal supplement) |
| Laxminarayan (a) | 2006 | Sub‐Saharan Africa | Societal (implied) | Treatment | 10 years | Mortality | Clear description of costs and sources, although cost parameters are not tabulated |
| Laxminarayan (b) | 2004 | Sub‐Saharan Africa | Provider (implied) | Treatment | 5, 10 and 20 years | Infections treated | Clear description of costs and sources, although cost parameters are not tabulated |
| Describe and justify model (15.) | Parameter uncertainty for all parameters and structural uncertainty (20b.) | Advanced Analyses | ||||||
|---|---|---|---|---|---|---|---|---|
| First author | Model type | Pre‐published model (Y/N) | Sensitivity analysis methods used | Includes cost parameters? | Probabilistic decision analysis (Y/N) | Value of information analysis (Y/N) | Resource allocation or programme budgeting (Y/N) | Spatial modelling (Y/N) |
| Okell | Individual | Y | Univariate and probabilistic | N | N | N | N | Y |
| Stuckey | Individual | Y | Univariate and probabilistic and structural | Only univariate | N | N | N | N |
| Briët (a) | Individual | Y | Probabilistic | N | N | N | N | N |
| Briët (b) | Individual | Y | Probabilistic | N | N | N | N | N |
| Briët (c) | Individual | Y | Scenario and probabilistic and structural | N | N | N | N | N |
| Crowell | Individual | Y | Multivariate | N | N | N | N | N |
| Okosun (a) | Deterministic | N | Scenario | N | N | N | N | N |
| Durhama | Deterministic | N | Scenario and probabilistic | Y | Y | N | N | N |
| Okosun (b) | Deterministic | N | Scenario | N | N | N | N | N |
| Maire | Individual | Y | Probabilistic | Y | Y | Y | N | N |
| Ross | Individual | Y | Multivariate | Y | N | N | N | N |
| Okosun (c) | Deterministic | N | Scenario | N | N | N | N | N |
| Luza | Deterministic | Y | Probabilistic | Y | Y | N | N | N |
| Tediosi (a) | Individual | Y | Multivariate | Mentioned but not quantified in main paper | N | N | N | N |
| Tediosi (b) | Individual | Y | Scenario | Y | N | N | N | N |
| Laxminarayan (a) | Deterministic | Y | Scenario | Y | N | N | N | N |
| Laxminarayan (b) | Deterministic | N | Univariate | Y | N | N | N | N |
a
Dengue studies, all others are on malaria.